Why Is Theo-24 XR So Hard to Find? [Explained for 2026]

If you've been trying to fill a Theo-24 XR prescription and keep running into empty shelves or pharmacy rejections, you're not alone. Theophylline extended-release — sold under the brand name Theo-24 and now largely available as a generic — has been experiencing persistent supply disruptions since 2022, with no clear end in sight as of 2026.

This guide explains the root causes of the shortage, which strengths are most affected, and what you can do today to keep your prescription filled.

What Is Theo-24 XR?

Theo-24 XR is an extended-release formulation of theophylline, a methylxanthine bronchodilator used to treat chronic asthma and COPD (emphysema and chronic bronchitis). The "24" in the name refers to its once-daily dosing — a 24-hour release profile that provides continuous airway support. It comes in 100 mg, 200 mg, 300 mg, and 400 mg capsules.

The original Theo-24 brand was manufactured by Endo Pharmaceuticals, but brand-name versions have been largely discontinued. Today, most patients rely on generic theophylline extended-release capsules or tablets. These generics are therapeutically equivalent but may have different release profiles — an important point we'll return to below.

Is There an Active Shortage of Theo-24 XR in 2026?

Yes. The American Society of Health-System Pharmacists (ASHP) has maintained an active shortage listing for Theophylline 24-Hour Extended Release Capsules and Tablets since August 2023, with updates continuing through September 2025. As of early 2026, availability remains intermittent — meaning you may find it one month and struggle the next.

The shortage is not uniform across all strengths. Here's the general picture:

100 mg and 200 mg: Generally more available, though spot shortages still occur.

300 mg: Intermittently available; supply varies by region and manufacturer.

400 mg: Most significantly affected. Both Glenmark and Rhodes have had 400 mg on back order with no estimated release date. Glenmark also recalled multiple batches of 400 mg tablets in August 2025 due to dissolution test failures.

600 mg: Also frequently out of stock at major manufacturers.

Why Is Theo-24 XR So Difficult to Find?

Several structural factors make theophylline extended-release vulnerable to supply disruptions:

1. Very Few Manufacturers Remain

Between 2010 and 2018, nearly every major brand-name version of theophylline XR was discontinued — including Theo-24, Uniphyl, Slo-Bid, and Theo-Dur. As these brands exited the market, production consolidated to a small number of generic manufacturers. Today, only a handful of companies (including Endo, Glenmark, Rhodes, and Alembic) produce theophylline extended-release products. When any one of them faces a production issue, the ripple effect is immediate.

2. Thin Profit Margins Discourage New Entrants

Generic theophylline ER is inexpensive — typically $10 to $40 per month without insurance. This affordability is great for patients but means slim margins for manufacturers. With limited profit potential, new pharmaceutical companies have little incentive to invest in manufacturing capacity for this drug. This keeps the supplier pool small and the risk of shortage high.

3. Complex Extended-Release Manufacturing

Extended-release formulations are more technically demanding to produce than immediate-release tablets. The dissolution profile must meet strict USP specifications (Drug Release Test 6 for Theo-24 capsules), and failures — like the August 2025 Glenmark recall — can pull significant inventory from the market at once.

4. Declining Prescribing but Stable Demand Among Long-Term Patients

Theophylline is no longer a first-line treatment for asthma or COPD — inhaled therapies have largely replaced it in clinical guidelines. However, a core group of patients — particularly those who can't use inhalers effectively, those in lower-income situations who need affordable oral options, and elderly patients already stabilized on theophylline — continues to depend on it. This stable but niche demand doesn't justify significant manufacturing investment.

How Has the Shortage Evolved Over Time?

Understanding the timeline puts today's situation in context:

2010–2018: Progressive discontinuation of all major brand-name products. Market consolidates to a few generic manufacturers.

2019–2021: Initial reports of intermittent shortages, particularly for higher-strength extended-release tablets. ASHP begins monitoring.

2022–2024: Supply disruptions become more widespread, compounded by broader pharmaceutical supply chain challenges. Multiple strengths affected simultaneously. ASHP shortage listing created August 2023.

2025–2026: Ongoing intermittent availability. Glenmark recalls 400 mg batches in August 2025. No new manufacturers have entered the market to fill the gap.

What Can You Do If You Can't Find Theo-24 XR?

You have more options than you might think:

Use medfinder: medfinder.com calls pharmacies near you to check which ones can fill your theophylline prescription — saving you hours of calling around yourself.

Try independent pharmacies: They often use different wholesalers than chain pharmacies and may have stock when CVS, Walgreens, and Rite Aid don't.

Ask your doctor about a different strength: If your usual 400 mg dose is unavailable, two 200 mg capsules may be an option — but only with your doctor's approval and updated serum monitoring.

Consider compounding pharmacies: Some compounding pharmacies can prepare theophylline in custom doses if standard formulations are unavailable. Ask your doctor if this is appropriate.

Try mail-order pharmacy: Your insurance plan's mail-order pharmacy may have different supply sources and better stock consistency.

Discuss alternatives with your provider: If shortages are causing consistent treatment gaps, your doctor may recommend transitioning to tiotropium (Spiriva), a combination inhaler, or another bronchodilator class.

Don't Wait Until You're Out

The most important thing you can do is plan ahead. Start your refill search 7 to 10 days before you run out. This gives you a buffer to call around, use medfinder, or wait for a pharmacy to restock. For the latest updates on availability, see our Theo-24 XR shortage update for 2026.

Looking for step-by-step strategies? Read our guide on how to find Theo-24 XR in stock near you.